U.S. RESEARCH ROUNDUP-Albemarle, Ellington Financial, Savara

Altus Power

16/05/2023 07:43

May 16 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several
U.S.-listed companies, including Albemarle, Ellington Financial and Savara on Tuesday. 
    
    HIGHLIGHTS
                 * Albemarle Corp  ALB.N : Baird raises to outperform rating 
 
                 * Ellington Financial Inc  EFC.N : KBW raises to outperform from market perform 
 
                 * Savara Inc  SVRA.O : Jefferies raises to buy from hold 
 
 Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are
in alphabetical order.     
    
                 * Advansix Inc  ASIX.N : Piper Sandler cuts target price to $50 from $54 
 
                 * Albemarle Corp  ALB.N : Baird raises target price to $288 from $222 
 
                 * Albemarle Corp  ALB.N : Baird raises to outperform rating 
 
                 * Altus Power Inc  AMPS.N : Evercore ISI cuts target price to $10 from $12 
 
                 * Beam Global  BEEM.O : TD Cowen cuts target price to $11 from $12 
 
                 * Coinbase Global Inc  COIN.O : Berenberg initiates with hold rating and $55 price target 
 
                 * CTI Biopharma Corp  CTIC.O : SVB Securities cuts target price to $9.1 from $13 
 
                 * CTI Biopharma Corp  CTIC.O : SVB Securities cuts to market perform from outperform 
 
                 * Cymabay Therapeutics Inc  CBAY.O : Oppenheimer raises target price to $16 from $14 
 
                 * Douglas Emmett Inc  DEI.N : Jefferies cuts target price to $9 from $10.50 
 
                 * Edgewell Personal Care Co  EPC.N : Jefferies raises target price to $48 from $44 
 
                 * Edgewise Therapeutics Inc  EWTX.O : JP Morgan cuts target price to $24 from $25 
 
                 * Elevation Oncology Inc  ELEV.O : SVB Securities raises target price to $5 from $1 
 
                 * Ellington Financial Inc  EFC.N : KBW raises to outperform from market perform 
 
                 * Flowserve Corp  FLS.N : TD Cowen raises target price to $45 from $42 
 
                 * Fluent Inc  FLNT.O : Canaccord Genuity cuts target price to $3 from $3.50 
 
                 * Fulcrum Therapeutics Inc  FULC.O : Credit Suisse cuts target price to $6.5 from $8 
 
                 * Grocery Outlet Holding Corp  GO.O : Roth MKM raises target price to $29 from $26 
 
                 * Heico Corp  HEI.N : Credit Suisse raises target price to $210 from $190 
 
                 * Inotiv Inc  NOTV.O : Jefferies cuts target price to $7.25 from $7.50 
 
                 * Lattice Semiconductor Corp  LSCC.O : Jefferies raises target price to $102 from $96 
 
                 * Molina Healthcare Inc  MOH.N : Stephens cuts target price to $335 from $350 
 
                 * Northern Oil and Gas Inc  NOG.N : Truist Securities cuts target price to $58 from $60 
 
                 * Palomar Holdings Inc  PLMR.O : KBW raises target price to $64 from $59 
 
                 * Palomar Holdings Inc  PLMR.O : KBW raises to outperform from market perform 
 
                 * PBF Energy Inc  PBF.N : JP Morgan cuts target price to $56 from $60 
 
                 * PGT Innovations Inc  PGTI.N : JP Morgan raises target price to $27 from $23.5 
 
                 * PGT Innovations Inc  PGTI.N : Truist Securities raises target price to $29 from $27 
 
                 * Sarepta Therapeutics Inc  SRPT.O : RBC raises target price to $218 from $197 
 
                 * Savara Inc  SVRA.O : Jefferies raises to buy from hold 
 
                 * Savara Inc  SVRA.O : Jefferies raises target price to $4 from $2 
 
                 * Sutro Biopharma Inc  STRO.O : Jefferies cuts target price to $20 from $25 
 
                 * Terns Pharmaceuticals Inc  TERN.O : JP Morgan raises target price to $10 from $9 
 
                 * TPG Inc  TPG.O : Evercore ISI cuts target price to $33 from $34 
 
                 * Verastem Inc  VSTM.O : Alliance Global Partners cuts target price to $4.5 from $5.5 
 
                 * Verve Therapeutics Inc  VERV.O : Credit Suisse cuts target price to $31 from $32 
 
                 * Verve Therapeutics Inc  VERV.O : JP Morgan cuts target price to $34 from $36 
 
                 * Vor Biopharma Inc  VOR.O : Jonestrading initiates with buy rating; price target $18 
 
                 * Welltower Inc  WELL.N : RBC raises target price to $87 from $82 
 
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))